These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35300211)

  • 21. Momordica charantia polysaccharides alleviate diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and barrier via NF-κB pathway.
    Ji S; Zhang Q
    Allergol Immunopathol (Madr); 2022; 50(3):62-70. PubMed ID: 35527657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Costunolide ameliorates intestinal dysfunction and depressive behaviour in mice with stress-induced irritable bowel syndrome
    Li X; Liu Q; Yu J; Zhang R; Sun T; Jiang W; Hu N; Yang P; Luo L; Ren J; Wang Q; Wang Y; Yang Q
    Food Funct; 2021 May; 12(9):4142-4151. PubMed ID: 33977961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome.
    Liu DR; Xu XJ; Yao SK
    World J Gastroenterol; 2018 Jan; 24(1):46-57. PubMed ID: 29358881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender Differences in Serotonin Signaling in Patients with Diarrhea-predominant Irritable Bowel Syndrome.
    Katsumata R; Shiotani A; Murao T; Ishii M; Fujita M; Matsumoto H; Haruma K
    Intern Med; 2017; 56(9):993-999. PubMed ID: 28458330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No synergistic effect of fecal microbiota transplantation and shugan decoction in water avoidance stress-induced IBS-D rat model.
    Meng Y; Feng Y; Hang L; Zhou Y; Wang E; Yuan J
    Front Microbiol; 2022; 13():995567. PubMed ID: 36171751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electroacupuncture protects the intestinal mucosal barrier in diarrhea-predominant Irritable Bowel Syndrome rats by regulating the MCs/Tryptase/PAR-2/MLCK pathway.
    Han XY; Song XG; Ma WL; Fang M; Zhu JW; Ruan JR; Li KW; Zou L; Liao LM; Li XM; Wang ZY; Fang YC; Chu HR
    Am J Transl Res; 2024; 16(3):781-793. PubMed ID: 38586088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How Serotonin Level Fluctuation Affects the Effectiveness of Treatment in Irritable Bowel Syndrome.
    Vahora IS; Tsouklidis N; Kumar R; Soni R; Khan S
    Cureus; 2020 Aug; 12(8):e9871. PubMed ID: 32968548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of 5-HT and NR2B contributes to visceral hypersensitivity in irritable bowel syndrome in rats.
    Chen MX; Chen Y; Fu R; Liu SY; Yang QQ; Shen TB
    Am J Transl Res; 2016; 8(12):5580-5590. PubMed ID: 28078028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the mechanism of Xingpi Capsule in diarrhea predominant-irritable bowel syndrome treatment based on multiomics technology.
    Qian W; Li W; Chen X; Cui L; Liu X; Yao J; Wang X; Liu Y; Li C; Wang Y; Wang W
    Phytomedicine; 2023 Mar; 111():154653. PubMed ID: 36641976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients.
    Kerckhoffs AP; Ter Linde JJ; Akkermans LM; Samsom M
    Neurogastroenterol Motil; 2008 Aug; 20(8):900-7. PubMed ID: 18363639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acupuncture relieves the visceral pain of diarrhea-predominant irritable bowel syndrome rats by regulating P2X4 expression.
    Tang HY; Chen XQ; Wang H; Chu HR; Zhu CF; Huang S; Zhang MT; Shen GM
    Am J Transl Res; 2022; 14(8):5563-5573. PubMed ID: 36105029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine.
    Kerckhoffs AP; ter Linde JJ; Akkermans LM; Samsom M
    Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G1053-60. PubMed ID: 22323131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LMWP (S3-3) from the Larvae of
    Peng S; Ling X; Rui W; Jin X; Chu F
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. microRNA-495 reduces visceral sensitivity in mice with diarrhea-predominant irritable bowel syndrome through suppression of the PI3K/AKT signaling pathway via PKIB.
    Fei L; Wang Y
    IUBMB Life; 2020 Jul; 72(7):1468-1480. PubMed ID: 32187820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of electroacupuncture of "Hegu" (LI4) and "Zusanli" (ST36) on intestinal sensitivity and motility in irritable bowel syndrome rats].
    Qin Y; Guo MW; Lan Y; Wang YF; Wang S; Ji MX; Ren XX; Zhu WL
    Zhen Ci Yan Jiu; 2020 Apr; 45(4):293-8. PubMed ID: 32333534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effect of
    Wu Y; Li S; Lv L; Jiang S; Xu L; Chen H; Li L
    Food Funct; 2024 Apr; 15(7):3692-3708. PubMed ID: 38488110
    [No Abstract]   [Full Text] [Related]  

  • 37. [The relationship between adherens junction and tight junction and clinical symptoms in patients with diarrhea predominant irritable bowel syndrome].
    Zhang M; Chen CY; Hu Y; Lyu B
    Zhonghua Nei Ke Za Zhi; 2020 Jan; 59(1):40-46. PubMed ID: 31887835
    [No Abstract]   [Full Text] [Related]  

  • 38. Serotonin signaling is altered in irritable bowel syndrome with diarrhea but not in functional dyspepsia in pediatric age patients.
    Faure C; Patey N; Gauthier C; Brooks EM; Mawe GM
    Gastroenterology; 2010 Jul; 139(1):249-58. PubMed ID: 20303355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological properties of 3-amino-5,6,7,8-tetrahydro-2-[4-[4-(quinolin-2-yl)piperazin-1-yl]butyl]quinazolin-4(3H)-one (TZB-30878), a novel therapeutic agent for diarrhea-predominant irritable bowel syndrome (IBS) and its effects on an experimental IBS model.
    Tamaoki S; Yamauchi Y; Nakano Y; Sakano S; Asagarasu A; Sato M
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1315-23. PubMed ID: 17540858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermal growth factor upregulates serotonin transporter and its association with visceral hypersensitivity in irritable bowel syndrome.
    Cui XF; Zhou WM; Yang Y; Zhou J; Li XL; Lin L; Zhang HJ
    World J Gastroenterol; 2014 Oct; 20(37):13521-9. PubMed ID: 25309082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.